The classic website will no longer be available as of June 25, 2024. Please use the modernized
Working… Menu

TENDU Vaccine in Patients With Relapse After Primary Radical Prostatectomy

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT04701021
Recruitment Status : Active, not recruiting
First Posted : January 8, 2021
Last Update Posted : November 29, 2023
Information provided by (Responsible Party):
Ultimovacs ASA

No Study Results Posted on for this Study
Recruitment Status : Active, not recruiting
Actual Primary Completion Date : August 31, 2023
Estimated Study Completion Date : December 31, 2023